Filing search / Kineta, Inc. / "Drug Pricing"

8-K

EX-99.6

KANT Kineta, Inc.

22 Dec 22

Kineta Completes Reverse Merger with Yumanity Therapeutics

5:02pm

) expanded the availability of lower pricing under the 340B drug pricing program by adding new entities to the program; (5) expanded the eligibility criteria … . At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals

424B3

KANT Kineta, Inc.

10 Nov 22

Prospectus supplement

4:21pm

to physicians and other healthcare providers or marketing expenditures and drug pricing. Several states also impose other marketing restrictions … and state legislation designed to, among other things, bring more transparency to drug pricing, review the relationship between pricing and manufacturer

8-K/A

EX-99.3

h4mnx9d

3 Feb 21

Other Events

4:59pm

8-K/A

EX-99.1

bn72w kn2kblvdu6wk

3 Feb 21

Other Events

4:59pm

424B3

48f144q4

12 Nov 20

Prospectus supplement

6:08am